Circa 2021 face_with_colon_three
A company recently developed a novel system capable of printing biological tissue in a blindingly fast 30 seconds. Ultimately, this new method could, one day, help bring an end to diabetes, according to a blog post shared on the Ecole Polytechnique Federale de Lausanne’s (EPFL’s) official website.
Called Readily3D, the company’s technology has seen widespread use in a large-scale European project to build a living model of the human pancreas, which could also provide a safe alternative for testing new drugs.
Comments are closed.